Abingdon Health (UK) Performance
| ABDX Stock | 7.25 0.50 6.45% |
The firm shows a Beta (market volatility) of -0.1, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Abingdon Health are expected to decrease at a much lower rate. During the bear market, Abingdon Health is likely to outperform the market. At this point, Abingdon Health Plc has a negative expected return of -0.51%. Please make sure to confirm Abingdon Health's total risk alpha, maximum drawdown, and the relationship between the jensen alpha and treynor ratio , to decide if Abingdon Health Plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Abingdon Health Plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor 673:671 | Last Split Date 2021-12-02 |
1 | Abingdon Health Achieves Strong AGM Support - TipRanks | 11/19/2024 |
| Begin Period Cash Flow | 3.2 M |
Abingdon |
Abingdon Health Relative Risk vs. Return Landscape
If you would invest 1,025 in Abingdon Health Plc on August 29, 2024 and sell it today you would lose (300.00) from holding Abingdon Health Plc or give up 29.27% of portfolio value over 90 days. Abingdon Health Plc is generating negative expected returns and assumes 2.2464% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Abingdon, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Abingdon Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Abingdon Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Abingdon Health Plc, and traders can use it to determine the average amount a Abingdon Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ABDX |
Estimated Market Risk
| 2.25 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Abingdon Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Abingdon Health by adding Abingdon Health to a well-diversified portfolio.
Abingdon Health Fundamentals Growth
Abingdon Stock prices reflect investors' perceptions of the future prospects and financial health of Abingdon Health, and Abingdon Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Abingdon Stock performance.
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.18 | ||||
| Profit Margin | (0.21) % | ||||
| Operating Margin | (0.04) % | ||||
| Current Valuation | 13.35 M | ||||
| Shares Outstanding | 189.52 M | ||||
| Price To Book | 6.11 X | ||||
| Price To Sales | 2.24 X | ||||
| Revenue | 6.13 M | ||||
| Gross Profit | 2.08 M | ||||
| EBITDA | (916 K) | ||||
| Net Income | (1.27 M) | ||||
| Total Debt | 1.05 M | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (1.66 M) | ||||
| Total Asset | 5.09 M | ||||
| Retained Earnings | (28.76 M) | ||||
About Abingdon Health Performance
Assessing Abingdon Health's fundamental ratios provides investors with valuable insights into Abingdon Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Abingdon Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Abingdon Health is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about Abingdon Health Plc performance evaluation
Checking the ongoing alerts about Abingdon Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Abingdon Health Plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Abingdon Health Plc generated a negative expected return over the last 90 days | |
| Abingdon Health Plc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 6.13 M. Net Loss for the year was (1.27 M) with profit before overhead, payroll, taxes, and interest of 2.08 M. | |
| Abingdon Health generates negative cash flow from operations | |
| About 43.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Abingdon Health Achieves Strong AGM Support - TipRanks |
- Analyzing Abingdon Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Abingdon Health's stock is overvalued or undervalued compared to its peers.
- Examining Abingdon Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Abingdon Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Abingdon Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Abingdon Health's stock. These opinions can provide insight into Abingdon Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Abingdon Stock Analysis
When running Abingdon Health's price analysis, check to measure Abingdon Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abingdon Health is operating at the current time. Most of Abingdon Health's value examination focuses on studying past and present price action to predict the probability of Abingdon Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abingdon Health's price. Additionally, you may evaluate how the addition of Abingdon Health to your portfolios can decrease your overall portfolio volatility.